MCRC Director’s Update – April 2022
April 2022 sees us officially launch the new vision of the Cancer Research UK Manchester Centre and our aim of driving translational research from the lab to the clinic. Read More
MCRC Director’s Update – March 2022
Visiting leadership in Kenya, five more years of funding for the Cancer Research UK Manchester Centre, and a visit to Westminster to launch On Cancer close an eventful March for the MCRC. Read More
On Cancer Westminster Launch
On 3 March 2022, to mark the launch of On Cancer, Policy@Manchester organised a panel discussion in Westminster to spotlight the policy recommendations that could help improve the lives of patients impacted by cancer. Read More
The ALETHEIA framework in radiation oncology
Dr Marianne Aznar explains the ALETHEIA Framework, an AI toolkit developed by Rolls-Royce, and how it is being applied to radiation oncology Read More
New era for Kenyan healthcare begins
Representatives of the MCRC partnership were in Kenya for the 14th March to mark the development of a Comprehensive Cancer Care Services network. Read More
MCRC Director’s Update – February 2022
TARGET National, Stampede, and DETERMINE clinical trials, as well as activities from World Cancer Day and Equality Diversity and Inclusivity cap off February at the MCRC. Read More
Thomas Kedward
We speak to Thomas Kedward about his PhD and the use of proteogenomics to connect somatic mutations to signalling in breast cancer patient-derived organoids. Read More
Introducing On Cancer
Professor Rob Bristow outlines the importance of the On Cancer publication and engagement of policy makers alongside our unique research and technologies here in Manchester. Read More
Hadiyat Ogunlayi
We speak to Hadiyat Ogunlayi about breast cancer and her MB-PhD investigating the relationship between a stromal wound healing phenotype and breast density as a mechanism for breast cancer development. Read More
Cancer researchers across the UK join forces to find drugs for rare cancers
DETERMINE is the first UK national precision medicine trial in rare cancers, testing a range of therapies specifically targeting key genetic changes in cancer cells. Read More
Cancer Revolution: Science, Innovation and Hope
Our blog covering the SIM exhibition, Cancer Revolution: Science, Innovation and Hope, which spotlights the pioneering work of our researchers here at the MCRC. Read More
MCRC Director’s Update – December 2021
At the end of 2021, we look back and reflect on the some of our major accomplishments and challenges of the past year, and a look ahead to 2022. Read More
MCRC Director’s Update – November 2021
Developing international collaborations, the Paterson Building reaching its highest point of construction, and a series of conferences, seminars and events close off an eventful November at the MCRC. Read More
Madeleine Strach
We speak to Madeleine Strach about rare cancers and her work with The Christie Colorectal and Peritoneal Oncology Centre (CPOC) research group on appendix cancer. Read More
